Cerence Inc. CRNC 深 滬
等待開盤 06-13 09:30:00 美东时间
10.62
-0.180
-1.67%
華盛通- 最 高11.13
- 今 開10.77
- 成交量 87.16万股
- 最 低 10.435
- 昨 收 10.80
- 總市值 4.80亿
- 52周最高 13.738
- 市盈率 靜 --
- 換手率 1.93%
- 52周最低 5.85
- 委 比 -5.50%
- 總股本 4518.78万
- 歷史最高 139.00
- 量 比 0.75
- 振 幅 6.44%
- 歷史最低 2.34
- 每 手 1
- 風險率 1.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shares of software companies are trading lower as stronger-than-expected U.S. payroll growth in May is eroding confidence in a Fed rate cut. Also, the sector has seen few catalysts in the last week since the Microsoft-Anthropic funding deal on May 29.
Shares of software companies are trading lower as stronger-than-expected U.S. p...
06-06 00:52
Shares of companies within the broader technology sector are trading higher amid overall market strength. The sector may be rallying in response to AMD CEO Lisa Su's warm comments about an expansion in the CPU market and Lenovo Group's strong Q4 financial results.
Shares of companies within the broader technology sector are trading higher ami...
05-23 03:43
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Goldman Sachs Maintains Neutral on Cerence, Raises Price Target to $9
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $8 to $9.
05-09 01:48
Cerence stock down after Q2 earnings
Shares of Cerence (CRNC) fell 8% on Friday after the company reported second-quarter results. Cerence posted a Q2 GAAP EPS of $0.04. Revenue declined 17.7% year over year to $64.2M, though it beat an...
05-09 01:06
财报速睇 | Cerence Inc. 2026财年Q1营收0.64亿美元，同比下降17.9%；归母净利润0.02亿美元，同比下滑90.9%
华盛资讯5月8日讯，Cerence Inc.公布2026财年Q1业绩，公司Q1营收0.64亿美元，同比下降17.9%，归母净利润0.02亿美元，同比下滑90.9%。
05-08 11:50
财报速睇 | Cerence Inc. 2026财年Q2营收0.64亿美元，同比下降17.7%；归母净利润0.02亿美元，同比下滑92.3%
华盛资讯5月8日讯，Cerence Inc.公布2026财年Q2业绩，公司Q2营收0.64亿美元，同比下降17.7%，归母净利润0.02亿美元，同比下滑92.3%。
05-08 06:15
Cerence Sees Q3 GAAP EPS $(0.02)-$0.07 vs $0.10 Est; Sees Sales $68.000M-$72.000M vs $68.216M Est
Cerence (NASDAQ:CRNC) is looking for Q3 GAAP EPS of $(0.02)-$0.07 vs $0.10 analyst estimate. sees sales of $68.000 million-$72.000 million vs $68.216 million analyst estimate.
05-08 04:23
Cerence Files Patent Infringement Lawsuit Against Amazon Over Alexa-Enabled Smart Devices
https://storage.courtlistener.com/recap/gov.uscourts.txed.245499/gov.uscourts.txed.245499.1.0.pdf
05-05 22:58
